Incyte bags Pemazyre FDA approval for cholangiocarcinoma treatment

pharmanewsdaily- April 18, 2020 0

Pemazyre FDA approval : US biopharma company Incyte has bagged accelerated approval from the US Food and Drug Administration (FDA) for Pemazyre (pemigatinib) for the ... Read More

Incyte secures FDA priority review for pemigatinib in cholangiocarcinoma

pharmanewsdaily- December 3, 2019 0

Delaware-based pharma company Incyte has secured priority review for pemigatinib from the US Food and Drug Administration (FDA) for the treatment of locally advanced or ... Read More

Innovent Biologics and Incyte announce $391.5m partnership for cancer drugs in China

pharmanewsdaily- December 17, 2018 0

Innovent Biologics, a leading Chinese biopharma company, has struck a landmark deal with Incyte, a prominent US pharmaceutical firm, to develop and commercialize three investigational ... Read More